Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin B9Vitamin B9 (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center

Itelman et al., Israel Medical Association Journal, 22:5
May 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 162 COVID-19 patients in Israel, showing lower vitamin B9 levels associated with increased COVID-19 severity.
Study covers vitamin B9 and vitamin B12.
Itelman et al., 31 May 2020, retrospective, Israel, peer-reviewed, 24 authors, study period February 2020 - April 2020.
This PaperVitamin B9All
I n February 2020, the World Health Organization designated the name Coronavirus disease-2019 (COVID-19) to a clinical condition caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [1]. The virus was initially identified in December of 2019 as a cause for a cluster of pneumonia cases in several provinces in China. Its clinical features range from asymptomatic carriage, flu-like symptoms including cough, fever, general weakness, myalgia, and respiratory failure requiring mechanical ventilation. There are several reports of the virus having non-respiratory clinical manifestations such as diarrhea, myocarditis and even hemorrhagic necrotizing encephalopathy [2][3][4]. The disease is highly infectious with a reproductive number (R0) ranging from 2.2-3.5 [5], which explains its rapid spread throughout the world. As of April 2020, the worldwide patient population was 1,617,576 with 96,939 deaths. These numbers continued to dramatically increase. Accumulating evidence suggests that in contrast to the initial, mild disease caused by viral replication, more severe manifestations of disease are immunemediated with a cytokine storm characteristic of its advanced, lethal stages [6]. Israel's first experience with the virus was atypical, comprising a mission to bring home the 11 Israeli citizens onboard the Diamond Princess cruise ship and who had not yet tested positive for the virus. On the night of 11 February 2020, those patients were flown to Israel via a private jet and immediately transferred to the quarantine facility at Sheba Medical Center, Tel Hashomer. Of that group, two patients later tested positive for the virus. The quarantine center, later converted into Department of Internal Medicine: Corona Care Unit, was the first internal ward department in Israel, designated to treat COVID-19 patients. The first COVID-19 case diagnosed in Israel, a 40-year-old male who returned from Italy, was diagnosed on 20 February 2020, and was hospitalized as an inaugural patient. From that moment on and up to the present time, the department continues to admit patients and treats the
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit